￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Medical News

Activity and safety of crizotinib (Xalkori) in ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Efficacy of Lorlatinib

2025-10-19 11:44:20

Check Details
Learn more about the new anti-cancer drug Sotorasib about non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Mobocertinib receives FDA priority review status for the treatment of exon 20 mutated non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Do you know the main diagnostic methods for lung cancer?

2025-10-19 11:44:20

Check Details
The effect of Lorlatinib in the first-line treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
How effective is lorlatinib treatment?

2025-10-19 11:44:20

Check Details
The efficacy and safety of dacomitinib (Dozerun) in the treatment of lung cancer

2025-10-19 11:44:20

Check Details
The efficacy of dacomitinib (Duozerun) in lung cancer

2025-10-19 11:44:20

Check Details
What is the safety of the new lung cancer drug dacomitinib (Dozerun)?

2025-10-19 11:44:20

Check Details
Is Crizotinib (Xalkori) better than chemotherapy in terms of efficacy?

2025-10-19 11:44:20

Check Details
Which lung cancers can Lorlatinib be used for?

2025-10-19 11:44:20

Check Details
Category
相关知识